NCT06989645View on ClinicalTrials.gov

A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee Osteoarthritis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Osteoarthritis of Knee
Interventions
DRUG

SYN321

Intra-articular

DRUG

Placebo

Intra-articular

Trial Locations (1)

Unknown

RECRUITING

Cinical Trial Consultants AB, Uppsala

Sponsors
All Listed Sponsors
collaborator

CTC Clinical Trial Consultants AB

INDUSTRY

lead

Synartro AB

INDUSTRY